123 related articles for article (PubMed ID: 28376523)
21. The association of low penetrance genetic risk modifiers with colorectal cancer in lynch syndrome patients: a systematic review and meta-analysis.
Donald N; Malik S; McGuire JL; Monahan KJ
Fam Cancer; 2018 Jan; 17(1):43-52. PubMed ID: 28508326
[TBL] [Abstract][Full Text] [Related]
22. Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome.
Dillon JL; Gonzalez JL; DeMars L; Bloch KJ; Tafe LJ
Hum Pathol; 2017 Dec; 70():121-128. PubMed ID: 29107668
[TBL] [Abstract][Full Text] [Related]
23. Hereditary Colorectal Cancer Syndromes.
Wells K; Wise PE
Surg Clin North Am; 2017 Jun; 97(3):605-625. PubMed ID: 28501250
[TBL] [Abstract][Full Text] [Related]
24. [Hereditary colorectal cancer : An update on genetics and entities in terms of differential diagnosis].
Rau TT; Dawson H; Hartmann A; Rüschoff J
Pathologe; 2017 May; 38(3):156-163. PubMed ID: 28474162
[TBL] [Abstract][Full Text] [Related]
25. Risk of metachronous colorectal cancer following colectomy in Lynch syndrome: a systematic review and meta-analysis.
Anele CC; Adegbola SO; Askari A; Rajendran A; Clark SK; Latchford A; Faiz OD
Colorectal Dis; 2017 Jun; 19(6):528-536. PubMed ID: 28407411
[TBL] [Abstract][Full Text] [Related]
26. Endometrial cancer: Molecular markers and management of advanced stage disease.
Arend RC; Jones BA; Martinez A; Goodfellow P
Gynecol Oncol; 2018 Sep; 150(3):569-580. PubMed ID: 29843906
[TBL] [Abstract][Full Text] [Related]
27. Molecular Genetics of Endometrial Carcinoma.
Bell DW; Ellenson LH
Annu Rev Pathol; 2019 Jan; 14():339-367. PubMed ID: 30332563
[TBL] [Abstract][Full Text] [Related]
28. Current clinical topics of Lynch syndrome.
Tanakaya K
Int J Clin Oncol; 2019 Sep; 24(9):1013-1019. PubMed ID: 29744602
[TBL] [Abstract][Full Text] [Related]
29. Endometrial Cancer: Is This a New Disease?
Moore K; Brewer MA
Am Soc Clin Oncol Educ Book; 2017; 37():435-442. PubMed ID: 28561715
[TBL] [Abstract][Full Text] [Related]
30. [Lynch syndrome: genetic, clinical and diagnostic aspects].
Castro-Mujica MDC; Barletta-Carrillo C
Rev Gastroenterol Peru; 2018; 38(3):265-279. PubMed ID: 30540731
[TBL] [Abstract][Full Text] [Related]
31. Risk factors for endometrial cancer: An umbrella review of the literature.
Raglan O; Kalliala I; Markozannes G; Cividini S; Gunter MJ; Nautiyal J; Gabra H; Paraskevaidis E; Martin-Hirsch P; Tsilidis KK; Kyrgiou M
Int J Cancer; 2019 Oct; 145(7):1719-1730. PubMed ID: 30387875
[TBL] [Abstract][Full Text] [Related]
32. Lynch Syndrome: Current management In 2019.
Menahem B; Alves A; Regimbeau JM; Sabbagh C
J Visc Surg; 2019 Dec; 156(6):507-514. PubMed ID: 31445799
[TBL] [Abstract][Full Text] [Related]
33. Molecular pathology of Lynch syndrome.
Cerretelli G; Ager A; Arends MJ; Frayling IM
J Pathol; 2020 Apr; 250(5):518-531. PubMed ID: 32141610
[TBL] [Abstract][Full Text] [Related]
34. Universal endometrial cancer tumor typing: How much has immunohistochemistry, microsatellite instability, and MLH1 methylation improved the diagnosis of Lynch syndrome across the population?
Kahn RM; Gordhandas S; Maddy BP; Baltich Nelson B; Askin G; Christos PJ; Caputo TA; Chapman-Davis E; Holcomb K; Frey MK
Cancer; 2019 Sep; 125(18):3172-3183. PubMed ID: 31150123
[TBL] [Abstract][Full Text] [Related]
35. Endometrial Cancer.
Lu KH; Broaddus RR
N Engl J Med; 2020 Nov; 383(21):2053-2064. PubMed ID: 33207095
[No Abstract] [Full Text] [Related]
36. Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer.
Latham A; Srinivasan P; Kemel Y; Shia J; Bandlamudi C; Mandelker D; Middha S; Hechtman J; Zehir A; Dubard-Gault M; Tran C; Stewart C; Sheehan M; Penson A; DeLair D; Yaeger R; Vijai J; Mukherjee S; Galle J; Dickson MA; Janjigian Y; O'Reilly EM; Segal N; Saltz LB; Reidy-Lagunes D; Varghese AM; Bajorin D; Carlo MI; Cadoo K; Walsh MF; Weiser M; Aguilar JG; Klimstra DS; Diaz LA; Baselga J; Zhang L; Ladanyi M; Hyman DM; Solit DB; Robson ME; Taylor BS; Offit K; Berger MF; Stadler ZK
J Clin Oncol; 2019 Feb; 37(4):286-295. PubMed ID: 30376427
[TBL] [Abstract][Full Text] [Related]
37. Genetic and genomic basis of the mismatch repair system involved in Lynch syndrome.
Tamura K; Kaneda M; Futagawa M; Takeshita M; Kim S; Nakama M; Kawashita N; Tatsumi-Miyajima J
Int J Clin Oncol; 2019 Sep; 24(9):999-1011. PubMed ID: 31273487
[TBL] [Abstract][Full Text] [Related]
38. Lynch syndrome-associated endometrial carcinoma with MLH1 germline mutation and MLH1 promoter hypermethylation: a case report and literature review.
Yokoyama T; Takehara K; Sugimoto N; Kaneko K; Fujimoto E; Okazawa-Sakai M; Okame S; Shiroyama Y; Yokoyama T; Teramoto N; Ohsumi S; Saito S; Imai K; Sugano K
BMC Cancer; 2018 May; 18(1):576. PubMed ID: 29783979
[TBL] [Abstract][Full Text] [Related]
39. Screening and surgical prophylaxis for hereditary cancer syndromes with high risk of endometrial and ovarian cancer.
Bercow AS; Eisenhauer EL
J Surg Oncol; 2019 Oct; 120(5):864-872. PubMed ID: 31355450
[TBL] [Abstract][Full Text] [Related]
40. The prevalence of Lynch syndrome in women with endometrial cancer: a systematic review protocol.
Ryan NAJ; Blake D; Cabrera-Dandy M; Glaire MA; Evans DG; Crosbie EJ
Syst Rev; 2018 Aug; 7(1):121. PubMed ID: 30115102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
